Zengzhang Liu
Overview
Explore the profile of Zengzhang Liu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
33
Citations
347
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Che J, Tong J, Kuang X, Zheng C, He N, Liu Z
J Hypertens
. 2024 May;
42(8):1390-1398.
PMID: 38690872
Background: Asymptomatic hyperuricemia (HUA) and normouricemic gout are common in clinic but recommendations for them in hypertension management are absent. The present study aims to simultaneously evaluate the effect of...
2.
Che J, He N, Kuang X, Zheng C, Zhou R, Zhan X, et al.
J Clin Endocrinol Metab
. 2024 Apr;
109(11):2847-2856.
PMID: 38625900
Context: While the association between n-3 polyunsaturated fatty acids (PUFAs) and cardiovascular (CV) events has been thoroughly examined, there is still a scarcity of research regarding their effect on the...
3.
Che J, Tong J, Kuang X, Zheng C, Zhou R, Song J, et al.
Front Nutr
. 2023 Oct;
10:1265662.
PMID: 37841406
Background: There are various cross-sectional studies that concluded that vitamin D is associated with blood pressure, but randomized controlled studies have not yielded consistent conclusions. Considering many limitations indeed, our...
4.
Che J, Song J, Long Y, Wang C, Zheng C, Zhou R, et al.
Angiology
. 2023 Aug;
75(8):786-795.
PMID: 37586709
The present study aimed to explore the association between the neutrophil-to-lymphocyte ratio (NLR) and prognosis of critically ill chronic heart failure patients. The records of 5298 patients who met the...
5.
Zhang B, Gyawali L, Liu Z, Du H, Yin Y
Case Rep Cardiol
. 2022 Aug;
2022:4042909.
PMID: 36032051
Immune checkpoint inhibitors (ICIs) have emerged in recent years as promising treatment options for several malignant tumors. However, ICI therapy has also been associated with various immune-related adverse events (irAEs),...
6.
Chen W, Liu Z, Xiao P, Xu Y, Li D, Xiong Q, et al.
J Cardiovasc Dev Dis
. 2022 Jun;
9(6).
PMID: 35735817
Cardioneuroablation (CNA) is proposed as a promising therapy for patients with sinoatrial node dysfunction (SND) that is mediated by excessive vagal tone. However, a series of urgent questions about CNA...
7.
Chen Q, Chen Y, Qin F, Du H, Gan C, Zhou B, et al.
Front Cardiovasc Med
. 2022 Jun;
9:870203.
PMID: 35707128
Background: Existing studies have shown that sacubitril-valsartan ameliorated atrial remodeling in atrial fibrillation (AF) and favored maintenance of sinus rhythm in patients with AF and heart failure. However, the effect...
8.
Chen W, Xiao P, Zhou G, Liu Z, Chen S, Du H, et al.
Pacing Clin Electrophysiol
. 2022 Apr;
45(8):975-983.
PMID: 35363390
Background: Pre-excited atrial fibrillation (AF) is associated with increased risk of life-threatening events. However, at times, patients with pre-excited AF still repetitively suffer from hemodynamic disturbance, with resistance to acute...
9.
Zhou H, Li Y, Xu Y, Liu H, Lai Y, Tan K, et al.
J Cardiovasc Transl Res
. 2022 Mar;
15(5):1215.
PMID: 35314950
No abstract available.
10.
Zhou H, Li Y, Xu Y, Liu H, Lai Y, Tan K, et al.
J Cardiovasc Transl Res
. 2021 Jul;
15(1):29-37.
PMID: 34282540
Increased sympathetic nervous activity is one of main contributors to pathogenesis and progression of hypertension. Renal denervation (RDN) has been demonstrated as a potential therapy for treatment of hypertension; however,...